Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
Author:
Affiliation:
1. Infectious Diseases Clinic, Department of Medicine, University of Udine, Italy
2. Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston
3. GST Micro, LLC, Durham, North Carolina
Funder
Melinta Therapeutics
Strategic Healthcare Communications
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/article-pdf/68/Supplement_3/S233/28280485/ciy1080.pdf
Reference20 articles.
1. Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy;Van Bambeke;Future Microbiol,2015
2. Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections;Bassetti;Expert Opin Drug Metab Toxicol,2017
3. Antimicrobial safety: focus on fluoroquinolones;Owens;Clin Infect Dis,2005
4. A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study;O’Riordan;Clin Infect Dis,2018
5. A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections;O’Riordan;Int J Infect Dis,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Updated Review on Clinically-Relevant Properties of Delafloxacin;Antibiotics;2023-07-28
2. Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?;Pharmaceutics;2023-03-01
3. The efficacy and adverse events of delafloxacin in the treatment of acute bacterial infections: A systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2022-09-28
4. Current international and national guidelines for managing skin and soft tissue infections;Current Opinion in Infectious Diseases;2022-01-19
5. New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections;Current Opinion in Infectious Diseases;2021-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3